Differences
This shows you the differences between two versions of the page.
| Both sides previous revision Previous revision Next revision | Previous revision | ||
|
en:start [2025/08/22 14:27] Gianluca Frustagli Updated logo (and relative imagemap) w/o FaBioCell. |
en:start [2025/08/24 15:38] (current) Gianluca Frustagli "Project GENEVAX": fixed link to logos. |
||
|---|---|---|---|
| Line 12: | Line 12: | ||
| The **[[https://www.iss.it|ISS]] - Core Facilities Technical-Scientific Service** is a centralized shared resource that provides access to instruments and technologies, as well as expert consultation, to scientific researchers. | The **[[https://www.iss.it|ISS]] - Core Facilities Technical-Scientific Service** is a centralized shared resource that provides access to instruments and technologies, as well as expert consultation, to scientific researchers. | ||
| - | {{map> :esagoni-eng.png?380|Core facilities}} | + | {{map> :esagoni-eng.png?300|Core facilities}} |
| /* "Logo" ad esagoni con mappa dei link. Le coordinate sono scalate sull'immagine ridimensionata, riscalando l'immagine occorre (purtroppo) riscalare a mano anche le coordinate. */ | /* "Logo" ad esagoni con mappa dei link. Le coordinate sono scalate sull'immagine ridimensionata, riscalando l'immagine occorre (purtroppo) riscalare a mano anche le coordinate. */ | ||
| * [[en:aree:calcolo:start|Area Calcolo Scientifico @ 124,100,175,100,201,144,176,189,125,189,99,145]] | * [[en:aree:calcolo:start|Area Calcolo Scientifico @ 124,100,175,100,201,144,176,189,125,189,99,145]] | ||
| Line 237: | Line 237: | ||
| <wrap bigger>**GENEVAX Project**</wrap> | <wrap bigger>**GENEVAX Project**</wrap> | ||
| - | {{ :aree:fabiocell:genevax-loghi.png?350 |}} | + | {{ :recycler:20250823-fabiocell:genevax-loghi.png?350 |}} |
| - | In the context of the **POR FESR, Key Enabling Technologies (KETs)** calls, the FaBioCell cell factory has recently received a loan from **[[http://www.lazioinnova.it|Lazio Innova]]** for the **[[http://www.evvivax.com/index.php/13-research/67-from-genes-to-translational-vaccines-genevax|GENEVAX]]** project, developed in collaboration with **[[http://www.evvivax.com|EVVIVAX]]**, a biotech dedicated to immunotherapy in the veterinary field [[en:aree:fabiocell:ricerca#genevax_project|[read more...]]] | + | In the context of the **POR FESR, Key Enabling Technologies (KETs)** calls, the FaBioCell cell factory has recently received a loan from **[[http://www.lazioinnova.it|Lazio Innova]]** for the **[[http://www.evvivax.com/index.php/13-research/67-from-genes-to-translational-vaccines-genevax|GENEVAX]]** project, developed in collaboration with **[[http://www.evvivax.com|EVVIVAX]]**, a biotech dedicated to immunotherapy in the veterinary field [[en:recycler:20250823-fabiocell:ricerca#genevax_project|[read more...]]] |
| Line 592: | Line 592: | ||
| <wrap bigger>**GENEVAX Project**</wrap> | <wrap bigger>**GENEVAX Project**</wrap> | ||
| - | {{ :aree:fabiocell:genevax-loghi.png?350 |}} | + | {{ :recycler:20250823-fabiocell:genevax-loghi.png?350 |}} |
| - | In the context of the **POR FESR, Key Enabling Technologies (KETs)** calls, the FaBioCell cell factory has recently received a loan from **[[http://www.lazioinnova.it|Lazio Innova]]** for the **[[http://www.evvivax.com/index.php/13-research/67-from-genes-to-translational-vaccines-genevax|GENEVAX]]** project, developed in collaboration with **[[http://www.evvivax.com|EVVIVAX]]**, a biotech dedicated to immunotherapy in the veterinary field [[en:aree:fabiocell:ricerca#genevax_project|[read more...]]] | + | In the context of the **POR FESR, Key Enabling Technologies (KETs)** calls, the FaBioCell cell factory has recently received a loan from **[[http://www.lazioinnova.it|Lazio Innova]]** for the **[[http://www.evvivax.com/index.php/13-research/67-from-genes-to-translational-vaccines-genevax|GENEVAX]]** project, developed in collaboration with **[[http://www.evvivax.com|EVVIVAX]]**, a biotech dedicated to immunotherapy in the veterinary field [[en:recycler:20250823-fabiocell:ricerca#genevax_project|[read more...]]] |
